Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It promotes weight loss through appetite control, gastric emptying, and GLP-1 receptor agonist effects
Retatrutide is the developmental designation for an investigational compound owned by Eli Lilly and Company
They will review your health history, discuss your weight loss goals, and determine if GLP-1 therapy is the right choice for you
However, the price reduction typically happens gradually as more manufacturers enter the market
US$ 26.65
US$ 28.15
US$ 21.51
US$ 24.61
